e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COVID-19 phenotypes: leading or misleading?
Luciano Gattinoni, Luigi Camporota, John J. Marini
Source:
Eur Respir J, 56 (2) 2002195; 10.1183/13993003.02195-2020
Journal Issue:
August
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luciano Gattinoni, Luigi Camporota, John J. Marini. COVID-19 phenotypes: leading or misleading?. Eur Respir J, 56 (2) 2002195; 10.1183/13993003.02195-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Acute respiratory distress syndrome
Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India
Diagnosing pulmonary oedema and permeability
Related content which might interest you:
Getting independent: what challenges should I expect?
Source: International Congress 2017 – Early Career Members session
Year: 2017
Asthma phenotypes: do metabolic pathways hold the key?
Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink
Year: 2017
Genetic variation and common diseases. Where are we? Where to go?
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008
Difficult-to-wean patients: can we avoid the problem?
Source: ERS Skills Course 2016
Year: 2016
Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - PRO
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020
Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - CON
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020
Genotype, phenotype and the environment in respiratory diseases: what contributes the most?
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012
Is asthma a risk factor for COVID-19? Are phenotypes important?
Source: ERJ Open Res, 7 (1) 00216-2020; 10.1183/23120541.00216-2020
Year: 2021
Equipment malfunction - - what could possibly go wrong?
Source: School Course 2012 - ERS School Course on Noninvasive Positive Pressure Ventilation
Year: 2012
Steroids related tuberculosis: Does a subgroup require a more cautious approach?
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
CF diagnosis in adulthood: a greater prevalence of classical forms than expected?
Source: Eur Respir J 2006; 28: Suppl. 50, 716s
Year: 2006
Contribution of causal factors to disease burden: how to interpret attributable fractions
Source: Breathe, 17 (4) 210086; 10.1183/20734735.0086-2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept